Clinical Trial Update: Validation of DaTscan for Detection of Parkinson Disease Related Disorders

View source ↗

Summary

A clinical trial update reports validation efforts for DaTscan (ioflupane I-123) in detecting Parkinson disease and related movement disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Movement Disorders
• Parkinson Disease

Drugs mentioned

• DaTscan (ioflupane)

Snippet

Sponsor: Wisconsin Institute for Neurologic and Sleep Disorders S.C. | Conditions: Parkinson Disease, Movement Disorders | Status: UNKNOWN